Re: Is an involved circumferential resection margin following oesphagectomy for cancer an important prognostic indicator?
Griffiths
Ewen A
EA
Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Pritchard
Susan A
SA
D017024:Chemotherapy, Adjuvant; D004938:Esophageal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016629:Esophagectomy / Q000009:adverse effects / Q000401:mortality; D019317:Evidence-Based Medicine; D006801:Humans; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local; D018365:Neoplasm, Residual; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome